Science
Mechanism of Action
While specific dermatological mechanisms for POLY(1-4 BUTANEDIOL)-27 are not extensively documented, its monomer, 1,4-Butanediol, serves as a solvent to aid ingredient dissolution and as a humectant to attract and retain moisture. As an integral component within broader polyurethane structures, this ingredient may also act as a binder or surface modifier, potentially contributing film-forming properties to skincare formulations.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Stability
The ingredient is expected to be stable within a pH range of 4 to 9, with certain polyurethanes containing butanediol demonstrating stability for up to 3 years between 5°C and 50°C. To maintain optimal stability, contact with heat, sparks, open flames, and strong oxidizers should be avoided.
Conflicts
- Strong oxidizers
Safety
Safety Profile
The Cosmetic Ingredient Review (CIR) Expert Panel indicated 'insufficient data' regarding the concentration of use for the 1,4-Butanediol monomer in cosmetic formulations. However, a safety assessment encompassing 66 polyurethane ingredients, some of which incorporate poly(1,4-butanediol), concluded they are safe for topical use under current practices and concentrations, with no detectable residual monomers. It is crucial to differentiate this from FDA warnings concerning oral ingestion of 1,4-Butanediol, which is classified as a Class I Health Hazard due to its metabolism into GHB; this warning is strictly for oral administration and does not pertain to the topical application of its polymeric form.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While POLY(1-4 BUTANEDIOL)-27 offers potential as a solvent, humectant, and binding agent in formulations, the absence of specific clinical efficacy data on skin and the 'insufficient data' status for its monomer's concentration mean its direct benefits for precision skincare are not yet fully established.
Related
Similar Ingredients
Finding similar ingredients…